Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) today. The company’s ...

In a report released today, Jeff Van Rhee from Craig-Hallum maintained a Buy rating on Cellebrite DI (CLBT – Research Report). The company’s ...

Fintel reports that on April 1, 2025, Craig-Hallum initiated coverage of Centrus Energy (NYSEAM:LEU) with a Buy recommendation. Analyst Price Forecast Suggests 126.74% Upside As of March 19, 2025, the ...

Centrus Energy (NYSE:LEU) +5.3% in Tuesday's trading as Craig Hallum initiates coverage with a Buy rating, saying the company ...

Craig Hallum assumed coverage on shares of Centrus Energy (NYSE:LEU – Free Report) in a report issued on Tuesday morning, Marketbeat reports. The firm issued a buy rating and a $129.00 price objective ...

Fintel reports that on March 31, 2025, Craig-Hallum initiated coverage of Turtle Beach (NasdaqGM:TBCH) with a Buy recommendation. As of March 19, 2025, the average one-year price target for Turtle ...

As of March 19, 2025, the average one-year price target for Veracyte is $46.31/share. The forecasts range from a low of $29.29 to a high of $56.70. The average price target represents an increase ...

Craig-Hallum raised the firm’s price target on Astera Labs (ALAB) to $125 from $105 and keeps a Buy rating on the shares. Astera had “another strong report and guide,” driven by its Aries ...

Craig Hallum started coverage on shares of Turtle Beach (NASDAQ:TBCH – Free Report) in a report published on Monday morning, MarketBeat reports. The firm issued a buy rating and a $23.00 target price ...

Detailed price information for Laird Superfood Inc (LSF-A) from The Globe and Mail including charting and trades.

On Thursday, Craig-Hallum adjusted its stance on Axon Enterprise (NASDAQ:AXON), downgrading the company’s stock rating from Buy to Hold, while increasing the price target to $625 from a previous ...